IPP Bureau

Piramal Pharma reports Q2 FY25 consolidated PAT at Rs. 22.59 Cr
Piramal Pharma reports Q2 FY25 consolidated PAT at Rs. 22.59 Cr

By IPP Bureau - October 25, 2024

Piramal Pharma has reported total income of Rs. 2,302.86 crores during the period ended September 30, 2024

Lonza extends collaboration with global biopharmaceutical partner for commercial-scale manufacture of ADCs
Lonza extends collaboration with global biopharmaceutical partner for commercial-scale manufacture of ADCs

By IPP Bureau - October 23, 2024

Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC

Jubilant Ingrevia appoints Vijay Srivastava as Chief of Operations
Jubilant Ingrevia appoints Vijay Srivastava as Chief of Operations

By IPP Bureau - October 23, 2024

He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates

Solara Active Pharma Sciences reports consolidated Q2 FY25 net profit at Rs. 8.01 Cr
Solara Active Pharma Sciences reports consolidated Q2 FY25 net profit at Rs. 8.01 Cr

By IPP Bureau - October 23, 2024

Solara Active Pharma Sciences has reported total income of Rs. 347.27 crores during the period ended September 30, 2024

European Food Safety Authority confirms safety of silica as food additive
European Food Safety Authority confirms safety of silica as food additive

By IPP Bureau - October 23, 2024

Silica is a proven and highly effective anti-caking agent that has been used for decades

Sumitomo Corporation entered into contract with Revorf
Sumitomo Corporation entered into contract with Revorf

By IPP Bureau - October 23, 2024

Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies

Zydus receives acceptability from WHO for Typhoid Vi Conjugate Vaccine ZyVac TCV
Zydus receives acceptability from WHO for Typhoid Vi Conjugate Vaccine ZyVac TCV

By IPP Bureau - October 23, 2024

Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies

Aptar bags contract to advance novel sterilization technology for medical devices
Aptar bags contract to advance novel sterilization technology for medical devices

By IPP Bureau - October 23, 2024

ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure

Lupin appoints Claus Jepsen as President, Global Specialty
Lupin appoints Claus Jepsen as President, Global Specialty

By IPP Bureau - October 23, 2024

Pradhan Mantri Bhartiya Janaushadhi Pariyojana achieves sales worth Rs. 1,000 croe in Oct. 2024
Pradhan Mantri Bhartiya Janaushadhi Pariyojana achieves sales worth Rs. 1,000 croe in Oct. 2024

By IPP Bureau - October 22, 2024

Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups

Mastek partners Innovaccer to transform value-based care and improve patient experience
Mastek partners Innovaccer to transform value-based care and improve patient experience

By IPP Bureau - October 22, 2024

This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences

KIMS signs MoU with Wipro GE Healthcare valuing upto Rs. 700 Cr
KIMS signs MoU with Wipro GE Healthcare valuing upto Rs. 700 Cr

By IPP Bureau - October 21, 2024

Health Minister Nadda inaugurates Medicine Update BJMFCON 2024
Health Minister Nadda inaugurates Medicine Update BJMFCON 2024

By IPP Bureau - October 21, 2024

Infant Mortality Rate in Bihar came down from 42 to 27 in 2020, and in Jharkhand, from 34 to 25 in 2020

Senores Pharmaceuticals gets SEBI nod for IPO
Senores Pharmaceuticals gets SEBI nod for IPO

By IPP Bureau - October 21, 2024

The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements

Sunbird Bio raises additional US $14 million to advance Alzheimer blood tech test
Sunbird Bio raises additional US $14 million to advance Alzheimer blood tech test

By IPP Bureau - October 21, 2024

Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI

Latest Stories

Interviews

Packaging